Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $349.9900 (2.74%) ($337.6600 - $351.9000) on Thu. Apr. 25, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.89% (three month average) | | RSI | 28 | | Latest Price | $349.9900(2.74%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | | Weekly Trend | REGN declines -8.2% a week on average for past two weeks. | | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -0.945% in a week (0% probabilities).
UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.945% (StdDev 1.89%) | | Hourly BBV | 0 () | | Intraday Trend | 2.8% | | | | | |
|
| Resistance Level | $379.96 | | 5 Day Moving Average | $340.44(2.81%) | | 10 Day Moving Average | $355.4(-1.52%) | | 20 Day Moving Average | $379.96(-7.89%) | | To recent high | -20.4% | | To recent low | 5% | | Market Cap | $37.109b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |